Bleakley Financial Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.63M | Buy |
108,586
+6,259
| +6% | +$152K | 0.07% | 243 |
|
|
2025
Q1 | $2.59M | Buy |
102,327
+18,268
| +22% | +$463K | 0.08% | 207 |
|
|
2024
Q4 | $2.23M | Sell |
84,059
-25,369
| -23% | -$673K | 0.07% | 235 |
|
|
2024
Q3 | $3.17M | Buy |
109,428
+2,914
| +3% | +$84.3K | 0.1% | 179 |
|
|
2024
Q2 | $2.98M | Sell |
106,514
-11,251
| -10% | -$315K | 0.09% | 211 |
|
|
2024
Q1 | $3.27M | Sell |
117,765
-14,008
| -11% | -$389K | 0.09% | 202 |
|
|
2023
Q4 | $3.79M | Sell |
131,773
-24,807
| -16% | -$714K | 0.12% | 163 |
|
|
2023
Q3 | $5.19M | Sell |
156,580
-13,969
| -8% | -$463K | 0.18% | 110 |
|
|
2023
Q2 | $6.26M | Buy |
170,549
+7,607
| +5% | +$279K | 0.2% | 95 |
|
|
2023
Q1 | $6.65M | Sell |
162,942
-8,519
| -5% | -$348K | 0.22% | 87 |
|
|
2022
Q4 | $8.79M | Buy |
+171,461
| New | +$8.79M | 0.31% | 63 |
|